Hologic, Inc.

Biopharma merger and acquisition value for the fourth quarter of 2024 reached $9.4bn from 34 transactions, 15 of which had disclosed values. At the top was H. Lundbeck’s $2.6bn purchase of publicly tr

FDA Panel Strongly Recommends Approval Of Colon Cancer Blood Test The Guardant Health, Inc. Shield, which screens the blood for markers of colon and rectal cancers, got the thumbs up from a US Food

Axena Health CEO Eileen Maus keeps a sign in her office that reads “Sisu [noun] [Finnish]: The extraordinary and indomitable Finnish spirit to never quit and go beyond all limitations, especially in t

Comment Period Extended On Diabetes Screening Tools Stakeholders interested in submitting comments on the potential use of digital health and AI to help detect diabetes and prediabetes have a month lo